Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairs.
D000293:Adolescent; D000328:Adult; D000921:Antibody-Producing Cells / Q000528:radiation effects; D000941:Antigens / Q000032:analysis; D001782:Blood Donors; D001792:Blood Platelets / Q000528:radiation effects; D001797:Blood Protein Electrophoresis; D016026:Bone Marrow Transplantation; D002648:Child; D003036:Cobalt Isotopes; D003582:Cytogenetics; D003601:Cytotoxicity Tests, Immunologic; D004798:Enzymes / Q000032:analysis; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006084:Graft Rejection; D006087:Graft vs Host Reaction; D006650:Histocompatibility Testing; D006689:Hodgkin Disease / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007938:Leukemia / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000628:therapy; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000941:Antigens; D003036:Cobalt Isotopes; D004798:Enzymes; D008727:Methotrexate